Researchers with the Energy Biosciences Institute (EBI) have employed a promising technique for improving the ability of cellulase enzymes to operate at advantageously high temperatures.

JBEI researchers have developed an enzyme-free ionic liquid pretreatment of cellulosic biomass that makes it easier to recover fermentable sugars for biofuels and to recycle the ionic liquid.

New evidence supports earlier findings that cancer therapy drugs based on a family of enzymes called metalloproteinases (MMPs) failed in clinical trials because they were aimed at the wrong target.

The power of chromatography for studying proteins and peptides can be substantially boosted with the addition of gold nanoparticles to polymer monolith surfaces.

A revolutionary X-ray analytical technique enables researchers at a glance to identify structural similarities and differences between multiple proteins under a variety of conditions and has already been used to gain valuable new insight into a prime protein target for cancer chemotherapy.

New metrics for analyzing data from small angle scattering (SAS) experiments should dramatically improve the ability of scientists to study the structures of macromolecules such as proteins and nanoparticles in solution.

Using an ultrahigh-precision microscopy technique, Berkeley Lab
researchers have uncovered a way to improve the collective catalytic activity of enzyme cocktails on cellulosic biomass, boosting the yields of sugars for the production of advanced biofuels.

Plants are being engineered with low xylan content and a higher proportion of cellulosic sugars for the production of advanced biofuels.

Using the tools of synthetic biology, JBEI researchers are engineering healthy plants whose lignocellulosic biomass can more easily be broken down into simple sugars for the production of clean, green and renewable advanced biofuels.

Berkeley Lab researchers have achieved a major advance in understanding how genetic information is transcribed from DNA to RNA by providing the first step-by-step look at the biomolecular machinery that reads the human genome.